Shanghai HeartCare (åæē®å»ē) Pre-IPO: Thoughts on Valuation
We forecast the sales of HeartCare's four key products, namely Captor, Intracranial Catheter, LAA Occluder, and embolic coil, and also provide an...
569 Views
Shanghai Bio-Heart (äøęµ·ē¾åæå®) Pre-IPO: Thoughts on Valuation
We provide a pre-money based valuation for Shanghai Bio-heart listing. We forecast the sales for its BRS and RDN respectively. We would re-iterate...
367 Views
Pre-IPO Shanghai Bio-Heart Biological Technology - Here Are the Strength and Concerns
The article analyzed Shanghai Bio-Heart Biological in terms of strength (core product, market potential) and concerns (competition, intensive...
437 Views
ECM Weekly (28th March 2021) - Bairong, Bilibili HK, Linklogis, Energy Monster, Zhihu, Monde Nissin
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
526 Views
Shanghai Bio-Heart (äøęµ·ē¾åæå®) Pre-IPO: Needs a Long Runway
The company's management were mainly from Microport Scientific. It has decent investor backing but we think it is short of blockbuster products.
713 Views